2-METHOXYACETOPHENONE

Names

[ Name ]:
2-METHOXYACETOPHENONE

[Synonym ]:
Ethanone,2-methoxy-1-phenyl
Acetophenone,2-methoxy
2-Methoxyacetophenone
1-phenyl-3-methoxyethan-1-one
methoxybenzoyl-methane
2-methoxy-1-phenylethan-1-one
2-methyl-1-phenylethanone
EINECS 223-802-4
α-Methoxyacetophenone
methoxyacetophenone
Ethanone, 2-methoxy-1-phenyl-
MFCD00008499
2-Methoxy-1-phenylethanone

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
237.9±0.0 °C at 760 mmHg

[ Melting Point ]:
7-8 °C(lit.)

[ Molecular Formula ]:
C₉H₁₀O₂

[ Molecular Weight ]:
150.174

[ Flash Point ]:
101.7±0.0 °C

[ Exact Mass ]:
150.068085

[ PSA ]:
26.30000

[ LogP ]:
1.40

[ Vapour Pressure ]:
0.0±0.4 mmHg at 25°C

[ Index of Refraction ]:
1.505

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves

[ Safety Phrases ]:
S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2914509090

Customs

[ HS Code ]: 2914509090

[ Summary ]:
HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%

Articles

Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.

Drug Des. Devel. Ther. 9 , 349-417, (2015)

Plumbagin (PLB) has exhibited a potent anticancer effect in preclinical studies, but the molecular interactome remains elusive. This study aimed to compare the quantitative proteomic responses to PLB ...

Pharmacokinetics and pharmacodynamics of ticagrelor and prasugrel in healthy male Korean volunteers.

Clin. Ther. 37(3) , 563-73, (2015)

A combination of clopidogrel and aspirin is the standard treatment for patients with acute coronary syndrome and those undergoing percutaneous coronary intervention. Two novel antiplatelet agents, tic...

Carboxylesterase 1-mediated drug-drug interactions between clopidogrel and simvastatin.

Biol. Pharm. Bull. 38(2) , 292-7, (2015)

Patients with coronary artery disease often receive concurrent treatment with clopidogrel and a hydroxymethylglutaryl (HMG)-CoA reductase inhibitor medication. Accordingly, potential drug-drug interac...